CBUS
Biotechnology · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Cibus, Inc. publishes a filing, an earnings call transcript or a press release.
Get CBUS alertsCarlo Broos is recorded as CFO at Cibus, Inc. (CBUS). Cibus, Inc. reported in an 8-K filed August 21, 2024 that Carlo Broos was appointed Interim Chief Financial Officer, effective September 30, 2024. Carlo Broos has spoken on 3 earnings calls across 1 company, most recently for Cibus, Inc. on May 14, 2026. Cibus, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cibus, Inc. includes Craig Wichner (CEO and Board Member), Michael Carr (CEO), Peter Beetham (CEO, COO and Board Member) and 7 others.
“the Company intends to appoint Carlo Broos, the Company's Senior Vice President of Finance, to serve as Interim Chief Financial Officer.”
“I would like to thank you for taking time to join us for CBIS First Quarter 2026 Financial Results and Business Update Conference Call and Webcast. Presenting with me today is Peter Betham, Co-Founder, Interim Chief Executive Officer, President and COO, and Greg Goetschel, Co-Founder and our Chief Scientific Officer.”
“I would like to thank you for taking time to join us for CBIS Third Quarter 2025 Financial Results and Business Update Conference Call and Webcast. Presenting with me today is Peter Beetham, Co-Founder, Interim Chief Executive Officer, President and COO, and Greg Gochel, Co-Founder and our Chief Scientific Officer.”
“I would like to thank you for taking time to join us for Cibus, Inc.'s first quarter 2025 Financial Results and business update conference call and webcast. Presenting with me today is Peter Beetham, cofounder, interim chief executive officer, president, and COO.”
CBUS
Biotechnology · Healthcare
CFO